Dennis Bittner, PhD

Nearly half of cancer patients do not discuss sexuality with their healthcare providers, but that doesn't mean it isn't a concern for them.

Advances in precision medicine for the treatment of melanoma include novel small-molecule inhibitors targeting signal transduction pathways in BRAF and NRAS mutations and cutting-edge drugs in the area of immune-modulation, whereby the patient's own immune system is mobilized to attack the tumor.

With an increasing number of cancer therapies being delivered orally, the importance of adherence continues to grow, and efforts to adapt adherence programs from other conditions like HIV could lead to better outcomes.

Effectively communicating with patients about what to expect before and after cancer treatment is an essential element of patient care.